Inari Medical, now part of Stryker, announced the launch of its next-generation InThrill thrombectomy system. According to ...

Inari Medical — now part of Stryker (NYSE: SYK) + — today announced the launch of its next-generation InThrill thrombectomy system. The company describes InThrill as the first and only purpose-built ...

InterVene’s Recana has been specifically designed to address the long-term complications associated with chronic venous ...

The ICB's acting medical director, Dr Andy Knox, told the meeting the hospital had now recruited enough interventional ...

Penumbra Inc (PEN) reports a 13.4% revenue increase, driven by US thrombectomy success, while navigating international ...

Direct endovascular thrombectomy for patients with acute ischemic stroke failed to achieve non-inferiority to combined bridging thrombolysis plus endovascular therapy, in a new meta-analysis.

The mean time to thrombectomy was 6.08 hours in the short time group vs 34.04 hours in the long time group. Their respective median times were 6.01 and 24.73 hours.

Explore Penumbra's Q2 2025 earnings highlights, featuring 13.4% growth, U.S. thrombectomy success, RUBY XL launch insights, and updated revenue guidance.

Children with ischemic stroke with large vessel occlusion appear to benefit from mechanical thrombectomy, researchers reported at the International Stroke Conference.“We know that, in adults ...

Penumbra’s U.S. thrombectomy business was the standout performer, with revenue jumping 22.6% YoY to $188.5 million. The company’s U.S. venous thromboembolism (VTE) revenue showed particularly strong ...